US 11491145
Combination therapies comprising targeted therapeutics
granted A61KA61K31/4375A61K31/502
Quick answer
US patent 11491145 (Combination therapies comprising targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4375, A61K31/502, A61K31/5025, A61K45/06